Gain Therapeutics

GANX • NASDAQ • Stock Fundamentals

Gain Therapeutics is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Gene Mack, with a market cap of $75.9M.

Market Cap$75.9M

Employees32.0

CEOGene Mack

CountryUnited States of America

Healthcare

Biotechnology

Most Recent EarningsMay 11, 2026 · 16 days agoQ1 2026

Next EarningsAug 11, 2026 · in 2 monthsBefore Market Open · Q2 2026

Financials

Based on Q1 2026 filing

Common questions about Gain Therapeutics

Gain Therapeutics (GANX) has a market capitalization of $75.9M and trades on NASDAQ.

Gain Therapeutics has approximately 32 employees.